Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (KCT0012817) titled 'Effectiveness of a Health Management App Using Wearable Device Data for Breast Cancer Survivors' on Oct. 21.

Study Type: Interventional Study

Study Design: Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT

Primary Sponsor: Yonsei University

Condition:

Neoplasms

Intervention: Behavioral : The intervention group was provided with a Galaxy Fit and used the ReBloomLens app, developed by the research team, for 4 weeks to manage and adhere to exercise and sleep recommendations. The control group was similarly provided with a Galaxy Fit

Recruitment Status: Not ...